| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Korro Bio, Inc. (KRRO) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. KRRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.54M | $20.26M | - | |
| 10% | 1.30M | $17.09M | - | |
| 10% | 1.30M | $17.09M | - | |
| 10% | 1.30M | $17.09M | - | |
| 10% | 1.30M | $17.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2021 | Lucchino David L.45 | President And CEO | Sale+OE | 9,196 | $42.50 | $390,830.00 | -2.9% | |
| Jan 27, 2021 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 8,000 | $42.50 | $340,000.00 | -20.1% | |
| Jan 6, 2021 | Lucchino David L.45 | President And CEO | Sale+OE | 27,586 | $38.57 | $1,063,917.43 | -1.7% | |
| Jan 4, 2021 | Lucchino David L.45 | President And CEO | Sale+OE | 34,104 | $33.21 | $1,132,739.97 | -3.5% | |
| Dec 22, 2020 | Marcus Joel S68 | Director | Sell | 49,700 | $34.25 | $1,702,412.07 | -1.6% | |
| Dec 17, 2020 | Lucchino David L.45 | President And CEO | Sale+OE | 1,120 | $42.64 | $47,755.23 | -0.3% | |
| Dec 17, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 8,000 | $40.63 | $325,001.20 | -8.9% | |
| Dec 16, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 24,000 | $37.07 | $889,720.00 | -9.9% | |
| Dec 16, 2020 | Lucchino David L.45 | President And CEO | Sale+OE | 40,542 | $37.84 | $1,534,061.20 | -3.0% | |
| Dec 9, 2020 | Lucchino David L.45 | President And CEO | Sale+OE | 13,514 | $32.93 | $444,983.59 | -4.0% |